JOONHYE KOOK: Open Payments
NPI 1639576325 · FORT LEE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 32 payments from 12 companies in 2025. Trend: 2023 $1,254 · 2024 $1,151 · 2025 $946
Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $308 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $142 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Amgen Inc. | 7 | $109 |
| SCILEX PHARMACEUTICALS INC. | 6 | $101 |
| Novo Nordisk Inc | 4 | $62 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
Products named: LINZESS, JARDIANCE, CREON, SHINGRIX, ZTLido, OTEZLA, Rybelsus, REXULTI.
Industry payments across NJ — which companies pay providers there.
